Clinical Trial Update: The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP) [Phase 2]

View source ↗

Summary

Phase 2 trial update examining the use of rituximab in acute thrombotic thrombocytopenic purpura (TTP) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University College, London | Conditions: Thrombotic Thrombocytopenic Purpura (TTP) | Phase 2 | Status: COMPLETED